SuvankarMajumdarMD

Pediatric Hematology & Oncology • Washington, DC

Assistant Professor, Pediatrics, University of Mississippi School of Medicine

Join to view full profile

Dr. Majumdar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Majumdar's full profile

Already have an account?

Office
111 Michigan Ave NW
Washington, DC 20010
Phone+1 202-476-3800

Fax+1 202-476-5685

Education & Training

University of Mississippi Medical CenterFellowship, Pediatric Hematology/Oncology, 2005 - 2008
Western Michigan University Homer Stryker MD School of MedicineResidency, Pediatrics, 2002 - 2005
University of Zimbabwe Huggins SOMClass of 1999

Certifications & Licensure

DC State Medical License 2017 - 2027
VA State Medical License 2021 - 2026
MD State Medical License 2017 - 2025
MS State Medical License 2005 - 2017
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Survey of Inhibitors in Plasma-Product Exposed Toddlers Start of enrollment: 2010 Jan 01
Completed
Phase 4
A Phase 1 Study of Continuous Intravenous L-citrulline During Sickle Cell Pain Crisis or Acute Chest Syndrome Start of enrollment: 2016 Feb 01
Completed
Phase 1

Publications & Presentations

PubMed

Genetic variants and effect modifiers of QT interval prolongation in patients with sickle cell disease.
Mengna Zhang, William B Hillegass, Xue Yu, Suvankar Majumdar, J Daryl Pollard
Gene. 2024-01-10
Variant in theGene in a Second Infant with Diamond-Blackfan Anemia.
Joshua Glass, Julia Weston, Amy Feldman Lewanda, Suvankar Majumdar
Case Reports in Hematology. 2024-01-01
2 citations
Clinical and Laboratory Correlates of QTc Duration in Adult and Pediatric Sickle Cell Disease.
Xue Yu, Suvankar Majumdar, J Daryl Pollard, Erin Jackson, Jarrod Knudson
American Journal of Medicine Open. 2023-12-01

Lectures

Outcomes in Children with Severe Vasculopathy from Sickle Cell Anemia after Treatment with Chronic Transfusion, Surgical Revascularization and/or Allogenic Hematopoeti...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Pioneering Gene Therapy as a Treatment for Sickle Cell DiseaseMay 16th, 2024